SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000914475-24-000033
Filing Date
2024-02-07
Accepted
2024-02-07 07:00:53
Documents
16
Period of Report
2024-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20240207.htm   iXBRL 8-K 23178
2 EX-99.1 q4-2023xearningsrelease.htm EX-99.1 230611
6 GRAPHIC nbix-20240207_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-24-000033.txt   447090

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20240207.xsd EX-101.SCH 1910
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20240207_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20240207_pre.xml EX-101.PRE 12514
17 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20240207_htm.xml XML 2713
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 24602094
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)